US$ 29.09
dpp-4 inhibitors vs. glp-1 agonist Clinical Use of It's the first in a
Description
After 56 weeks, the study participants in the liraglutide group achieved an 8.4% weight loss compared to 2.8% in the placebo group (95% CI: 6.0 to 5.1
Chang, C

The kidney in heart failure: an update

doi: 10.1080/14656566.2019.1571040 122 GenoveseSMannucciECerielloA

Certain patient factors may increase susceptibility to constipation on GLP-1 therapy
Note: Both Ozempic and Mounjaro are effective for diabetes management, but Ozempic vs Mounjaro for diabetes often comes down to other factors like patient response, tolerability, cost, and other health conditions
